세계의 세포 리프로그래밍 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년)

The global demand for Cell Reprogramming Market is presumed to reach the market size of nearly USD 738.47 MN by 2030 from USD 364.95 MN in 2022 with a CAGR of 9.21% under the study period 2023 - 2030.

Cell reprogramming refers to the process of changing the identity or properties of a mature or specialized cell back to a less specialized state, typically to a pluripotent or stem cell-like state. This procedure entails modifying the gene expression patterns of a cell and reprogramming its destiny, enabling it to recover the capability to differentiate into various cell types.

MARKET DYNAMICS:

The Cell reprogramming market's growth is driven by diverse factors at the forefront of biomedical innovation. Advances in regenerative medicine and the potential of induced pluripotent stem cells (iPSCs) to generate various cell types for tissue regeneration propel market expansion. The increasing incidence of chronic diseases fosters demand for personalized cell-based therapies derived from reprogrammed cells, offering potential treatments for conditions like cardiovascular diseases, neurodegenerative disorders, and diabetes. Moreover, cell reprogramming facilitates the creation of disease models using patient-specific cells, aiding drug development and screening. Ongoing technological advancements, including improved reprogramming techniques and genome editing tools, enhance precision and efficiency, widening the applications of cell reprogramming. Collaborations between industry players, government funding, and evolving regulatory frameworks further shape the market, influencing research, innovation, and commercialization efforts. These collective factors underscore the significance of cell reprogramming in advancing regenerative medicine, disease understanding, and personalized therapies, promising substantial impact in biomedical research and healthcare.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell reprogramming. The growth and trends of cell reprogramming industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cell reprogramming market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

• Sendai Virus-Based Reprogramming
• mRNA Reprogramming
• Episomal Reprogramming
• Others

By Application

• Research
• Therapeutic

By End-Use

• Research & Academic Institutes
• Biotechnology & Pharmaceutical Companies

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cell Reprogramming market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Reprogramming market include Thermo Fisher Scientific, Inc., Allele Biotech, Alstem, Stemcell Technologies Inc., Merck KGaA, Bio-Techne, REPROCELL, Lonza, FUJIFILM Corp. (Fujifilm Cellular Dynamics), Mogrify Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CELL REPROGRAMMING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Technology
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY TECHNOLOGY

• 5.1 Overview by Technology
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Technology
• 5.4 Sendai Virus-based Reprogramming Historic and Forecast Sales by Regions
• 5.5 mRNA Reprogramming Historic and Forecast Sales by Regions
• 5.6 Episomal Reprogramming Historic and Forecast Sales by Regions
• 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Research Historic and Forecast Sales by Regions
• 6.5 Therapeutic Historic and Forecast Sales by Regions

7 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-use
• 7.4 Research & Academic Institutes Historic and Forecast Sales by Regions
• 7.5 Biotechnology & Pharmaceutical Companies Historic and Forecast Sales by Regions

8 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CELL REPROGRAMMING COMPANIES

• 9.1. Cell Reprogramming Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF CELL REPROGRAMMING INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Thermo Fisher Scientific Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Allele Biotech
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Alstem
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Stemcell Technologies Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Merck KGaA
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Bio-Techne
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. REPROCELL
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Lonza
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. FUJIFILM Corp. (Fujifilm Cellular Dynamics)
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Mogrify Ltd.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies